According to the SEC Form 4 filings, Reich Kristian, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $8,135,616 | 10 | 100 |
| 2026-07-27 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 1,100 0.0013% | $20.00 | $22,000 | -36.49% | |
| 2026-07-22 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 2,448 0.0031% | $20.00 | $48,960 | -31.89% | |
| 2026-07-21 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 50,000 0.0604% | $20.02 | $1M | -34.99% | |
| 2026-07-20 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 43,700 0.0558% | $20.09 | $877,933 | -30.81% | |
| 2026-07-15 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 16,105 0.0195% | $20.01 | $322,261 | -32.11% | |
| 2026-06-17 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 50,000 0.0695% | $19.43 | $971,500 | -19.49% | |
| 2026-06-16 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 50,000 0.0669% | $18.70 | $935,000 | -18.18% | |
| 2026-06-15 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 50,000 0.0669% | $18.89 | $944,500 | -18.99% | |
| 2025-12-09 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 72,908 0.1135% | $14.43 | $1.05M | +15.53% | |
| 2025-12-08 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 130,000 0.2042% | $15.08 | $1.96M | +11.28% | |
| 2024-02-28 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 60,000 0.0961% | $55.00 | $3.3M | -18.29% | |
| 2024-02-27 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 58,922 0.0944% | $55.00 | $3.24M | -15.23% | |
| 2024-02-21 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 1,078 0.0017% | $55.30 | $59,618 | -12.98% | |
| 2024-02-20 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 20,000 0.0335% | $57.44 | $1.15M | -15.53% | |
| 2024-02-16 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 20,000 0.035% | $60.15 | $1.2M | -22.06% | |
| 2024-02-15 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 20,000 0.0351% | $60.16 | $1.2M | -22.16% | |
| 2024-02-14 | Sale | MoonLake Immunotherapeutics MLTX | Chief Scientific Officer | 20,000 0.0364% | $62.42 | $1.25M | -25.2% |